News
The current fear is that bird flu, H5N1, will become the next big pandemic. Only the mRNA platform is nimble enough to ...
The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.
The Trump administration is waging war against mRNA vaccines despite President Donald Trump having called them the “gold standard” when his admin rolled out the COVID shots […] ...
The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...
The number of changes to vaccine policy in the United States in recent weeks is dizzying — and we’ve just hit Code Red.
(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...
The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...
Robert F. Kennedy, Jr., the new Secretary of the U.S. Department of Health and Human Services (HHS), recently announced that ...
(Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach ...
President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their ...
The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results